Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells.
Front Pharmacol. 2022 Sep 9;13:894535. doi: 10.3389/fphar.2022.894535. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36160379
Free PMC article.
Drug-Tolerant Persister Cells in Cancer Therapy Resistance.
Dhanyamraju PK, Schell TD, Amin S, Robertson GP.
Dhanyamraju PK, et al.
Cancer Res. 2022 Jul 18;82(14):2503-2514. doi: 10.1158/0008-5472.CAN-21-3844.
Cancer Res. 2022.
PMID: 35584245
Free PMC article.
Review.
Item in Clipboard
Targeting WEE1/AKT Restores p53-Dependent Natural Killer-Cell Activation to Induce Immune Checkpoint Blockade Responses in "Cold" Melanoma.
Dinavahi SS, Chen YC, Punnath K, Berg A, Herlyn M, Foroutan M, Huntington ND, Robertson GP.
Dinavahi SS, et al.
Cancer Immunol Res. 2022 Jun 3;10(6):757-769. doi: 10.1158/2326-6066.CIR-21-0587.
Cancer Immunol Res. 2022.
PMID: 35439317
Free PMC article.
Item in Clipboard
Cite
Cite